XJPX
2907
Market cap69mUSD
Oct 09, Last price
1,490.00JPY
1D
2.12%
1Q
-10.62%
Jan 2017
40.57%
Name
Ahjikan Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ahjikan Co., Ltd. operates within Japan as a manufacturer, distributor, and wholesaler of a broad selection of food items. Its extensive product range features prepared chicken eggs, sushi, surimi, tofu, traditional Japanese side dishes, vegetable and fish paste products, imitation crab, and goods derived from Burdock tea, alongside other food offerings. Furthermore, the company engages in the cultivation and sale of agricultural produce and distributes its products internationally. The firm, established in 1962, has its main headquarters situated in Hiroshima, Japan.
Key people
Keiichi Ashikaga
Chairman of the Board · since 2021
Tomoatsu Esumi
Senior Managing Executive Officer, Chief Director of Business Administration, Representative Director · since 2023
Koji Fukushima
Managing Executive Officer, Chief Director of Sales, Director · since 2025
Tomomitsu Hiraoka
Executive Officer, Director of Marketing · since 2025
Minoru Nakazawa
Executive Officer, Director of Logistics · since 2025
Kazuaki Sakai
Executive Officer, Director of Overseas Business, CEO of Subsidiary · since 2025
Chitoshi Sumida
Executive Officer, Deputy Chief Director of Business Administration · since 2022
Tomomi Takeda
Executive Officer, Deputy Chief Director of Business Administration, Director of Business Planning · since 2023
Naozumi Ashikaga
Executive President, Chairman of Subsidiary, Representative Director · since 2023
Nobuyoshi Yamamoto
Director · since 2023
Yoshitake Yoshino
Managing Executive Officer, Chief Director of Development, Director of Health Food Business, Director · since 2025
Hiroshi Matsushige
Independent Director · since 2023
Hidenobu Matsutani
Independent Director · since 2023
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||